|
Age (years) (range)
|
61 (24–94)
|
|---|
|
Male sex
|
800 (81)
|
|
Current smokers
|
474 (48)
|
|
Previous CVD
|
229 (23)
|
|
Treated hypertension
|
334 (34)
|
|
Treated diabetes mellitus
|
124 (12)
|
|
BMI (kg/m2)
|
26.6 (24.3,29.2)
|
|
Prehospital thrombolysis
|
119 (12)
|
|
Aspirin
|
231 (23)
|
|
Statins
|
233 (23)
|
|
Total cholesterol (mmol/L)
|
4.9 (4.1,5.6)
|
|
HDL (mmol/L)
|
1.06 (0.88,1.30)
|
|
Triglycerides (mmol/L)
|
1.25 (0.89,1.78)
|
|
CRP (mg/L)
|
13.4 (7.0,31.3)
|
|
Admission glucose (mmol/L)
|
7.4 (6.3,9.0)
|
|
Fasting glucose (mmol/L)
|
5.8 (5.2,6.6)
|
|
HbA1c (%)
|
5.9 (5.6,6.3)
|
|
Peak Troponin T (ng/L)
|
3850 (1710,7250)
|
|
NT-ProBNP (pmol/L)
|
31 (10,118)
|
|
LV Ejection fraction (%)
|
50 (44,55)
|
|
D-dimer (ng/mL)
|
456 (287,796)
|
|
F1 + 2 (pmol/L)
|
246 (178,356)
|
| ETP (nM⋅min) |
1564 (1366,1743)
|
|
Time from onset of symptoms to blood sampling (hours) (range)
|
24 (5–118)
|
- Number (proportions) or median (25,75 percentiles) are given
-
BMI Body mass index, CVD Cardiovascular Disease, HDL High Density lipoprotein cholesterol, CRP C-reactive Protein, ETP endogenous thrombin potential
